share_log

Shockwave Medical Initiates All-Female Coronary Intravascular Lithotripsy Study To Treat Severely Calcified Cardiovascular Disease

Shockwave Medical Initiates All-Female Coronary Intravascular Lithotripsy Study To Treat Severely Calcified Cardiovascular Disease

冲击波医疗公司启动全女性冠状动脉内碎石术治疗严重钙化心血管疾病的研究
Benzinga Real-time News ·  2022/09/19 09:06
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions
Empower CAD是首个针对冠状动脉介入治疗的女性前瞻性研究
Study Seeks to Confirm Benefits of Shockwave's Coronary IVL in Females Who Historically Have Suffered Less Favorable Clinical Outcomes than Male Patients with Traditional Therapies
学习寻求确认Shockwave的冠状动脉IVL对女性的好处从历史上看,与使用传统疗法的男性患者相比,哪些患者的临床结果较差
SANTA CLARA, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting of all female patients – EMPOWER CAD – to determine whether the positive results from earlier coronary IVL studies with the Shockwave C2 Coronary IVL Catheter, which showed similar...
加利福尼亚州圣克拉拉,9月2022年10月19日(环球网)--开发血管内碎石术治疗严重钙化心血管疾病的先驱公司Shockwa...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发